Article(id=1322245763346845858, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322245734427112160, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1599753600000, acceptedDateStr=2020-09-11, onlineDate=1793177556120, onlineDateStr=2026-10-28, pubDate=1622304000000, pubDateStr=2021-05-30, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793177556120, onlineIssueDateStr=2026-10-28, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793177556120, creator=13701087609, updateTime=1793177556120, updator=13701087609, issue=Issue{id=1322245734427112160, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='10', pageStart='865', pageEnd='960', issueExtLink='null', onlineDate='null', pubDate='1622304000000', pubDateStr='2021-05-30', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793177549225, creator='13701087609', updateTime=1793177686658, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322246311269740715, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322245734427112160, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322246311269740716, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322245734427112160, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=886, endPage=892, ext={EN=ArticleExt(id=1322245763527200931, articleId=1322245763346845858, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Considerations for the bioequivalence study of oral antitumor generics, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

This paper takes the guidelines on bioequivalence study in China as the main basis, refers to the relevant requirements of international regulatory agencies, and takes the cytotoxic and small molecule targeted oral antitumor drugs as examples to give some considerations for the study design of bioequivalence of oral antitumor generics from the perspectives of science, ethics and review.

, authors=Fei-fei LIU, Jin-bo YANG, Yu-zhu WANG, authorsList=Fei-fei LIU, Jin-bo YANG, Yu-zhu WANG, authorCompany=null, correspAuthors=Yu-zhu WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322245765263642788, articleId=1322245763346845858, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=口服抗肿瘤仿制药生物等效性研究的考虑要点, columnId=1236331159400018080, journalTitle=中国新药杂志, columnName=新药注册与审评技术, runingTitle=null, highlight=null, articleAbstract=

以我国生物等效性研究相关指导原则为主要依据,参考国际监管机构相关要求,旨在从科学、伦理及审评的角度,以细胞毒、小分子靶向类口服抗肿瘤药为例,对口服抗肿瘤仿制药生物等效性研究考虑要点进行综述。

, authors=刘霏霏, 杨进波, 王玉珠, authorsList=刘霏霏, 杨进波, 王玉珠, authorCompany=null, correspAuthors=王玉珠, authorNote=

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

, correspAuthorsNote=
王玉珠,女,博士,主审审评员,主要从事药品审评工作。联系电话:(010)85243204,E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=dmhVtgHa7mx4v+oCzMpEsA==, magXml=v2+K8zZrAyouZYGqbUiK5Q==, pdfUrl=null, pdf=FgOJmXvihKU7RENMt6V7mg==, pdfFileSize=1190134, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=amAp8RnFtFe/MxK7Rdimaw==, mapNumber=null, fund=null)}, authors=[Author(id=1322245765485940905, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=liuff@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322245765548855467, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765485940905, language=EN, stringName=Fei-fei LIU, firstName=Fei-fei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245765620158636, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765485940905, language=CN, stringName=刘霏霏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

"}, bioImg=null, bioContent=

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322245765687267502, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322245765771153584, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765687267502, language=EN, stringName=Jin-bo YANG, firstName=Jin-bo, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245765838262449, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765687267502, language=CN, stringName=杨进波, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322245765884399795, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wangyzh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322245765951508661, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765884399795, language=EN, stringName=Yu-zhu WANG, firstName=Yu-zhu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245766027006134, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765884399795, language=CN, stringName=王玉珠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1322245766115086519, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=EN, orderNo=1, keyword=antitumor drug), Keyword(id=1322245766173806776, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=EN, orderNo=2, keyword=generic drug), Keyword(id=1322245766240915641, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=EN, orderNo=3, keyword=bioequivalence study), Keyword(id=1322245766320607418, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=EN, orderNo=4, keyword=experimental design), Keyword(id=1322245766379327675, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=CN, orderNo=1, keyword=抗肿瘤药), Keyword(id=1322245766433853628, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=CN, orderNo=2, keyword=仿制药), Keyword(id=1322245766505156797, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=CN, orderNo=3, keyword=生物等效性研究), Keyword(id=1322245766580654270, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, language=CN, orderNo=4, keyword=试验设计)], refs=[Reference(id=1322245766769397952, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=NMPA. 化学药物制剂人体生物利用度和生物等效性研究技术指导原则[EB/OL]. (2007) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2196/323492.html., articleTitle=null, refAbstract=null), Reference(id=1322245766828118209, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=NMPA. 以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则[EB/OL]. (2016) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2093/229256.html., articleTitle=null, refAbstract=null), Reference(id=1322245766895227074, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Draft Guidance on Capecitabine[EB/OL]. (2012) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Capecitabine_Tabs_20896_RC09-12.pdf., articleTitle=null, refAbstract=null), Reference(id=1322245766949753027, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Capecitabine product-specific bioequivalence guidance[EB/OL]. (2015) [2020-07]. https://www.ema.europa.eu/en/capecitabine-product-specific-bioequivalence-guidance., articleTitle=null, refAbstract=null), Reference(id=1322245767021056196, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 卡培他滨片原研地产说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E5%8D%A1%E5%9F%B9%E4%BB%96%E6%BB%A8%E7%89%87&pzwh=., articleTitle=null, refAbstract=null), Reference(id=1322245767109136581, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 长春瑞滨软胶囊原研进口说明书[EB/OL]. [2020-07]. http://172.16.0.34/cdess/zbsms/view?dcid=4c6e70a26e0cfa03a3fe3d3b99268e9c., articleTitle=null, refAbstract=null), Reference(id=1322245767176245446, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 替吉奥胶囊原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E6%9B%BF%E5%90%89%E5%A5%A5%E8%83%B6%E5%9B%8A&pzwh=., articleTitle=null, refAbstract=null), Reference(id=1322245767234965703, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Draft Guidance on Afatinib Dimaleate[EB/OL]. (2015) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Afatinib%20dimaleate_Oral%20tablet_201292_RC06-15.pdf., articleTitle=null, refAbstract=null), Reference(id=1322245767310463176, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 马来酸阿法替尼片原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E9%A9%AC%E6%9D%A5%E9%85%B8%E9%98%BF%E6%B3%95%E6%9B%BF%E5%B0%BC%E7%89%87&pzwh=., articleTitle=null, refAbstract=null), Reference(id=1322245767369183433, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Draft Guidance on Abiraterone Acetate[EB/OL]. (2018) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Abiraterone%20acetate_oral%20tablet_NDA%20202379_RV07-18.pdf., articleTitle=null, refAbstract=null), Reference(id=1322245767436292298, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 醋酸阿比特龙片原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E9%86%8B%E9%85%B8%E9%98%BF%E6%AF%94%E7%89%B9%E9%BE%99%E7%89%87&pzwh=., articleTitle=null, refAbstract=null), Reference(id=1322245767499206859, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Draft Guidance on Imatinib Mesylate[EB/OL]. (2014) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Imatinib_Mesylate_tab_21588_RV07-14.pdf., articleTitle=null, refAbstract=null), Reference(id=1322245767553732812, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药典委员会. 中华人民共和国药典[S]. 2015年版. 五部. 北京: 中国医药科技出版社, 附录119-124., articleTitle=null, refAbstract=null), Reference(id=1322245767612453069, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=NMPA. 生物等效性研究的统计学指导原则[EB/OL]. (2018) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2182/331454.html., articleTitle=null, refAbstract=null), Reference(id=1322245767679561934, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=CDE. 药物临床试验的生物统计学指导原则(征求意见稿)[EB/OL]. (2016) [2020-07]. http://www.cde.org.cn/zdyz.do?method=largePage&id=272., articleTitle=null, refAbstract=null), Reference(id=1322245767750865103, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=YU LX. FDA生物等效性标准[M]. 北京: 北京大学医学出版社, 2017: 36-38., articleTitle=null, refAbstract=null), Reference(id=1322245767822168272, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=NMPA. 高变异药物生物等效性研究技术指导原则[EB/OL]. (2018) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2182/331454.html., articleTitle=null, refAbstract=null), Reference(id=1322245767885082833, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=单爱莲, 权菊香, 吕媛. 新药临床试验方案设计的研究[J]. 中国临床药理学杂志, 2011, 27(1): 50-52., articleTitle=null, refAbstract=null), Reference(id=1322245767956386002, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=漆璐, 王瑜, 雷春璞, 等. 抗肿瘤药物临床试验质量管理探讨[J]. 中国临床药理学杂志, 2018, 34(12): 1479-1487., articleTitle=null, refAbstract=null), Reference(id=1322245769621524691, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=周运翱, 田晓花, 郝晓花, 等. 药物生物等效性临床试验中不依从/违背方案特点分析及管理策略[J]. 中国新药杂志, 2020, 29(8): 858-863., articleTitle=null, refAbstract=null), Reference(id=1322245769684439252, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=周心娜, 杨化兵, 游伟程, 等. 肿瘤医院规范化抗肿瘤药物临床试验管理模式构建的探讨[J]. 中国药物应用与监测, 2009, 6(5): 310-312., articleTitle=null, refAbstract=null)], funds=[Fund(id=1322245766668734655, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, awardId=2017ZX09101001, language=CN, fundingSource=国家“重大新药创制”科技重大专项资助项目(2017ZX09101001), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I10/886, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I10/886, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I10/886, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I10/886, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1622304000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
口服抗肿瘤仿制药生物等效性研究的考虑要点
收藏切换
PDF下载
刘霏霏 , 杨进波 , 王玉珠
中国新药杂志 | 新药注册与审评技术 2021,30(10): 886-892
收起
收藏切换
中国新药杂志 |新药注册与审评技术 2021 , 30 (10) : 886 -892
口服抗肿瘤仿制药生物等效性研究的考虑要点
全屏
[Author(id=1322245765485940905, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=liuff@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322245765548855467, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765485940905, language=EN, stringName=Fei-fei LIU, firstName=Fei-fei, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245765620158636, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765485940905, language=CN, stringName=刘霏霏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

"}, bioImg=null, bioContent=

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322245765687267502, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322245765771153584, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765687267502, language=EN, stringName=Jin-bo YANG, firstName=Jin-bo, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245765838262449, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765687267502, language=CN, stringName=杨进波, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322245765884399795, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wangyzh@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322245765951508661, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765884399795, language=EN, stringName=Yu-zhu WANG, firstName=Yu-zhu, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322245766027006134, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, authorId=1322245765884399795, language=CN, stringName=王玉珠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322245765414637733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, xref=null, ext=[AuthorCompanyExt(id=1322245765418832038, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322245765427220647, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322245763346845858, companyId=1322245765414637733, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
刘霏霏 , 杨进波, 王玉珠
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
王玉珠,女,博士,主审审评员,主要从事药品审评工作。联系电话:(010)85243204,E-mail:。
作者简介:

刘霏霏,女,硕士,审评员,主要从事药品审评工作。联系电话:(010)85243217,E-mail:。

Considerations for the bioequivalence study of oral antitumor generics
Fei-fei LIU , Jin-bo YANG, Yu-zhu WANG
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
出版时间: 2021-05-30
文章导航
收藏切换

以我国生物等效性研究相关指导原则为主要依据,参考国际监管机构相关要求,旨在从科学、伦理及审评的角度,以细胞毒、小分子靶向类口服抗肿瘤药为例,对口服抗肿瘤仿制药生物等效性研究考虑要点进行综述。

抗肿瘤药  /  仿制药  /  生物等效性研究  /  试验设计

This paper takes the guidelines on bioequivalence study in China as the main basis, refers to the relevant requirements of international regulatory agencies, and takes the cytotoxic and small molecule targeted oral antitumor drugs as examples to give some considerations for the study design of bioequivalence of oral antitumor generics from the perspectives of science, ethics and review.

antitumor drug  /  generic drug  /  bioequivalence study  /  experimental design
刘霏霏, 杨进波, 王玉珠. 口服抗肿瘤仿制药生物等效性研究的考虑要点. 中国新药杂志, 2021 , 30 (10) : 886 -892 .
Fei-fei LIU, Jin-bo YANG, Yu-zhu WANG. Considerations for the bioequivalence study of oral antitumor generics[J]. Chinese Journal of New Drugs, 2021 , 30 (10) : 886 -892 .
  • 国家“重大新药创制”科技重大专项资助项目(2017ZX09101001)
参考文献 引证文献
排序方式:
[1]
NMPA. 化学药物制剂人体生物利用度和生物等效性研究技术指导原则[EB/OL]. (2007) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2196/323492.html.
[2]
NMPA. 以药动学参数为终点评价指标的化学药物仿制药人体生物等效性研究技术指导原则[EB/OL]. (2016) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2093/229256.html.
[3]
FDA. Draft Guidance on Capecitabine[EB/OL]. (2012) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Capecitabine_Tabs_20896_RC09-12.pdf.
[4]
EMA. Capecitabine product-specific bioequivalence guidance[EB/OL]. (2015) [2020-07]. https://www.ema.europa.eu/en/capecitabine-product-specific-bioequivalence-guidance.
[5]
CDE. 卡培他滨片原研地产说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E5%8D%A1%E5%9F%B9%E4%BB%96%E6%BB%A8%E7%89%87&pzwh=.
[6]
CDE. 长春瑞滨软胶囊原研进口说明书[EB/OL]. [2020-07]. http://172.16.0.34/cdess/zbsms/view?dcid=4c6e70a26e0cfa03a3fe3d3b99268e9c.
[7]
CDE. 替吉奥胶囊原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E6%9B%BF%E5%90%89%E5%A5%A5%E8%83%B6%E5%9B%8A&pzwh=.
[8]
FDA. Draft Guidance on Afatinib Dimaleate[EB/OL]. (2015) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Afatinib%20dimaleate_Oral%20tablet_201292_RC06-15.pdf.
[9]
CDE. 马来酸阿法替尼片原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E9%A9%AC%E6%9D%A5%E9%85%B8%E9%98%BF%E6%B3%95%E6%9B%BF%E5%B0%BC%E7%89%87&pzwh=.
[10]
FDA. Draft Guidance on Abiraterone Acetate[EB/OL]. (2018) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Abiraterone%20acetate_oral%20tablet_NDA%20202379_RV07-18.pdf.
[11]
CDE. 醋酸阿比特龙片原研进口说明书[EB/OL]. [2020-07]. http://list.cde.org.cn/index/instruction?ypmc=%E9%86%8B%E9%85%B8%E9%98%BF%E6%AF%94%E7%89%B9%E9%BE%99%E7%89%87&pzwh=.
[12]
FDA. Draft Guidance on Imatinib Mesylate[EB/OL]. (2014) [2020-07]. https://www.accessdata.fda.gov/drugsatfda_docs/psg/Imatinib_Mesylate_tab_21588_RV07-14.pdf.
[13]
国家药典委员会. 中华人民共和国药典[S]. 2015年版. 五部. 北京: 中国医药科技出版社, 附录119-124.
[14]
NMPA. 生物等效性研究的统计学指导原则[EB/OL]. (2018) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2182/331454.html.
[15]
CDE. 药物临床试验的生物统计学指导原则(征求意见稿)[EB/OL]. (2016) [2020-07]. http://www.cde.org.cn/zdyz.do?method=largePage&id=272.
[16]
YU LX. FDA生物等效性标准[M]. 北京: 北京大学医学出版社, 2017: 36-38.
[17]
NMPA. 高变异药物生物等效性研究技术指导原则[EB/OL]. (2018) [2020-07]. http://www.nmpa.gov.cn/WS04/CL2182/331454.html.
[18]
单爱莲, 权菊香, 吕媛. 新药临床试验方案设计的研究[J]. 中国临床药理学杂志, 2011, 27(1): 50-52.
[19]
漆璐, 王瑜, 雷春璞, 等. 抗肿瘤药物临床试验质量管理探讨[J]. 中国临床药理学杂志, 2018, 34(12): 1479-1487.
[20]
周运翱, 田晓花, 郝晓花, 等. 药物生物等效性临床试验中不依从/违背方案特点分析及管理策略[J]. 中国新药杂志, 2020, 29(8): 858-863.
[21]
周心娜, 杨化兵, 游伟程, 等. 肿瘤医院规范化抗肿瘤药物临床试验管理模式构建的探讨[J]. 中国药物应用与监测, 2009, 6(5): 310-312.
2021年第30卷第10期
PDF下载
15
6
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-28
  • 出版时间:2021-05-30
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2020-09-11
基金
国家“重大新药创制”科技重大专项资助项目(2017ZX09101001)
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

王玉珠,女,博士,主审审评员,主要从事药品审评工作。联系电话:(010)85243204,E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322245763346845858
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏